Characterization of a soluble KGF receptor cDNA from human corneal and breast epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 13, 1998, Pages 2584-2593

  Liu, Janice J ^a,b   Shay, Jerry W ^c   Wilson, Steven E ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR; GENE PRODUCT; GROWTH FACTOR RECEPTOR; KERATINOCYTE GROWTH FACTOR;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CELL INTERACTION; CELL PROLIFERATION; CORNEA EPITHELIUM; HUMAN; HUMAN CELL; KERATINOCYTE; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR UPREGULATION;

3T3 CELLS; ALTERNATIVE SPLICING; ANIMALS; BLOTTING, WESTERN; BREAST; CELL LINE; CELLS, CULTURED; CORNEA; DNA, COMPLEMENTARY; EPITHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; GROWTH SUBSTANCES; HUMANS; MICE; MICE, INBRED BALB C; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECEPTORS, GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 0031793761     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA. 1989; 86:802-806.
2. Wilson SE, He Y-G, Weng J, Zieske JD, Jester JV, Schultz GS. Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor, on proliferation, motility and differentiation of human corneal epithelial cells. Exp Eye Res. 1994;59:665-78.
3. Wilson SE, Weng J, Chwang EL, Gollahon L, Leitch AM, Shay JW. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: alternative receptors. Cell Mol Biol. 1994;40:337-350.
4. Marchese C, Rubin J, Ron D, et al. Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF form EGF family. J Cell Physiol. 1990;144:326-332.
5. Miki T, Bottaro DP, Fleming TT, et al. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA. 1992;89:246-250.
6. Miki T, Fleming TP, Bottaro DP, Rubin JS, Ron D, Aaronson SA. Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science. 1991;251:72-75.
7. Yarden Y, Kuang WJ, Yang-Feng T, et al. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 1987;6:3341-51.
8. Bottaro DP, Rubin JS, Ron D, Finch PW, Florio C, Aaronson SA. Characterization of the receptor for keratinocyte growth factor. J Biol Chem. 1990;265:12767-12770.
9. Wilson SE, Walker JW, Chwang EL, He Y-G. Hepatocyte growth factor, keratinocyte growth factor, their receptors, fibroblast growth factor receptor-2, and the cells of the cornea. Invest Ophthalmol Vis Sci. 1993;34:2544-2561.
10. Wilson SE, Weng J, Blair S, He Y-G, Lloyd S. Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated high-proliferative capacity. Invest Ophthalmol Vis Sci. 1995;36:32-40.
11. Frohman MA. Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: thermal RACE. Methods Enzymol. 1993;218:340-56.
12. Ausubel FM, Brent R, Kingston RE, et al. Current Protocols in Molecular Biology. New York: John Wiley & Sons; 1997.
13. Hunter WM, Greenwood FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962; 194:495-496.
14. Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol. 1992;12:240-247.
15. LaRochelle WJ, Dirsch OR, Finch PW, et al. Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimera. J Cell Biol. 1995;129:357-366.
16. Marchese C, Sorice M, De Stefano C, Frati L, Torrisi MR. Modulation of keratinocyte growth factor receptor expression in human cultured keratinocytes. Cell Growth Diff. 1997;8:989-997.
17. Bottaro DP, Fortney E, Rubin JS, Aaronson SA. A keratinocyte growth factor receptor-derived peptide antagonist identifies part of the ligand binding site. J Biol Chem. 1993;268:9180-9183.
18. Sotozono C, Inatomi T, Nakamura M, Kinoshita S. Keratinocyte growth factor accelerates corneal epithelial wound healing in vivo. Invest Ophthalmol Vis Sci. 1995;36:1524-9.
19. Li DQ. Tseng SC Differential regulation of cytokine and receptor transcript expression in human corneal and limbal fibroblasts by epidermal growth factor, transforming growth factor-alpha, platelet-derived growth factor B, and interleukin-1 beta. Invest Ophthalmol Vis Sci. 1996;37:2068-80.
20. Li DQ, Tseng SC. Differential regulation of keratinocyte growth factor and hepatocyte growth factor/scatter factor by different cytokines in human corneal and limbal fibroblasts. J Cell Physiol. 1997;172:361-72.
21. Honma Y, Nishida K, Sotozono C, Kinoshita S. Effect of transforming growth factor-beta1 and -beta2 on in vitro rabbit corneal epithelial cell proliferation promoted by epidermal growth factor, keratinocyte growth factor, or hepatocyte growth factor. Exp Eye Res. 1997;65:391-6.
22. Wilson SE, Chen L, Mohan RR, Liang Q, Liu J. Expression of HGF, KGF, EGF, and receptor messenger RNAs following corneal epithelial wounding. Exp Eye Res. In press.
23. Park M, Crepaldi T, Gandino L, Giordano S, Longati P, Comoglio P. C-Terminal truncated forms of met, the hepatocyte growth factor receptor. Mol Cell Biol. 1991;11:5954-5962.
24. MacDonald RG, Tepper MA, Clairmont KB, Perregaux SB, Czech MP. Serum form of the rat insulin-like growth factor II/mannose 6-phosphate receptor is truncated in the carboxyl-terminal domain. J Biol Chem. 1989;264:3256-3261.
25. Zabrescky JR, Lam T, McKenzie SJ, Carney W. The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3. J Biol Chem. 1991;266:1716-1720.
26. DiStefano P, Johnson EM. Identification of a truncated form of the nerve growth factor receptor. Proc Natl Acad Sci USA. 1988;85:270-274.
27. Robb RJ, Kutny MR. Structure-function relationships for the IL 2-receptor system, IV: analysis of the sequence and ligand-binding properties of soluble tac protein. J Immunol. 1987;139: 855-860.
28. Novick D, Engelmann H, Wallach D, Rubinstein M. Soluble cytokine receptors are present in normal human urine. J Exp Med. 1989;170:1409-1414.
29. Gatanaga T, Hwang C, Kohr W, et al. Purification and characterization of an inhibitor (soluble tumor nectosis factor receptor) for tumor nectosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Proc Natl Acad Sci USA. 1990;87:8781-8784.
30. Kohno T, Brewer MT, Baker SL, et al. A second tumor necrosis factor receptor gene product can be shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA. 1990;87:8331-8335.
31. Shin YJ, Baynes RD, Hudson BG, Flowers CH, Shikne BS, Cook JD. Serum transferrin receptor is a truncated form of tissue receptor. J Biol Chem. 1990;265:19077-19081.
32. Weber W, Gill GN. Production of an epidermal growth factor receptor-related protein. Science. 1984;224:294-297.
33. Mosley B, Beckmann MP, March CJ, et al. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell. 1989;59:335-348.
34. Middlemas DS, Lindberg RA, Hunter T. trkB, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors. Mol Cell Biol. 1991;11:143-153.
35. Cascino I, Fiucci G, Papoff G, Ruberti G. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol. 1995;154:2706-2713.
36. Liu C, Cheng J, Mountz JD. Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. Biochem J. 1995;310:957-963.
37. Zimmer Y, Givol D, Yayon A. Multiple structural elements determine ligand binding of fibroblast growth factor receptors: evidence that both Ig domain 2 and 3 define receptor specificity. J Biol Chem. 1993;268:7899-7903.
38. Bobek G, Scott CD, Baxter RC. Secretion of soluble insulin-like growth factor-II/mannose 6-phosphate receptor by rat tissues in culture. Endocrinology. 1991;128:2204-2206.
39. Cheng J, Zhou T, Liu C, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 1994;263: 1759-1762.
40. Eisemann A, Ahn JA, Graziani G, Tronick SR, Ron D. Alternative splicing generates at least five different isoforms of the human basic-FGF receptor. Oncogene. 1991;6:1195-1202.
41. Jacques Y, Le Mauff B, Boeffard F, Godard A, Soulillou J-P. A soluble interleukin a receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity. J Immunol. 1987;139:2308-2316.
42. Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA. 1993;15:10705-10709.
43. Tiesman J, Hart CE. Identification of a soluble receptor for platelet-derived growth factor in cell-conditioned medium and human plasma. J Biol Chem. 1993;268:9621-9628.
44. Alcami A, Smith GL. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell. 1992;71:1992: 153-167.